Celera Axes 132 Jobs To Refocus On Drug Development | GenomeWeb

NEW YORK, June 11-Celera Genomics today announced a major restructuring that will eliminate 132 jobs and purge the company's genome sequencing and online information business.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.